Financials Synlogic, Inc.

Equities

SYBX

US87166L2097

Biotechnology & Medical Research

Market Closed - Nasdaq 01:30:00 26/06/2024 am IST 5-day change 1st Jan Change
1.55 USD +1.97% Intraday chart for Synlogic, Inc. -2.52% -59.74%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 83.31 75.24 168.7 53.6 35.38 18.15 -
Enterprise Value (EV) 1 -36.26 -25.2 32.07 -24.03 35.38 -2.354 -41.15
P/E ratio -1.52 x -1.31 x -2.22 x -0.83 x -0.44 x -0.42 x -11.9 x
Yield - - - - - - -
Capitalization / Revenue 37.5 x 138 x 96.2 x 45.4 x 10.5 x - -
EV / Revenue -16.3 x -46.2 x 18.3 x -20.4 x 10.5 x - -
EV / EBITDA - - - - - - -
EV / FCF 4,72,643 x 3,49,878 x -6,06,451 x - - - -
FCF Yield 0% 0% -0% - - - -
Price to Book - - - - - - -
Nbr of stocks (in thousands) 2,153 2,322 4,647 4,701 9,189 11,707 -
Reference price 2 38.70 32.40 36.30 11.40 3.850 1.550 1.550
Announcement Date 12/03/20 25/03/21 17/03/22 29/03/23 19/03/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 2.224 0.545 1.754 1.18 3.371 - -
EBITDA - - - - - - -
EBIT -54.41 -60.47 -60.76 -67.42 -55.16 - -
Operating Margin -2,446.45% -11,094.68% -3,464.37% -5,713.47% -1,636.34% - -
Earnings before Tax (EBT) -51.37 -59.17 -60.56 -66.15 -57.27 - -
Net income 1 -51.37 -59.17 -60.56 -66.15 -57.28 -43.9 -11.5
Net margin -2,309.94% -10,857.43% -3,452.74% -5,605.68% -1,699.26% - -
EPS 2 -25.50 -24.75 -16.35 -13.80 -8.810 -3.710 -0.1300
Free Cash Flow -76.72 -72.04 -52.88 - - - -
FCF margin -3,449.6% -13,217.43% -3,014.65% - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 12/03/20 25/03/21 17/03/22 29/03/23 19/03/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 0.592 0.244 0.152 0.678 0.106 0.174 0.035 0.393 2.769 0.008 - - -
EBITDA - - - - - - - - - - - - -
EBIT -15.14 -15.76 -16.02 -18.33 -17.3 -16.24 -15.65 -12.62 -10.64 - - - -
Operating Margin -2,558.28% -6,461.07% -10,537.5% -2,704.13% -16,323.58% -9,335.06% -44,725.71% -3,211.96% -384.29% - - - -
Earnings before Tax (EBT) -15.09 -15.7 -15.84 -17.91 -16.7 -15.62 -15.04 -12.08 -14.53 - - - -
Net income 1 -15.09 -15.7 -15.84 -17.91 -16.7 -15.62 -15.05 -12.08 -14.53 -31.56 -6 -4 -2.4
Net margin -2,548.82% -6,433.2% -10,422.37% -2,641.89% -15,750.94% -8,978.16% -42,994.29% -3,073.28% -524.88% -3,94,550% - - -
EPS 2 -2.400 -3.300 -3.300 -3.750 -3.600 -3.450 -3.150 -2.570 - -2.600 -0.5100 -0.3400 -0.2000
Dividend per Share - - - - - - - - - - - - -
Announcement Date 17/03/22 12/05/22 11/08/22 10/11/22 29/03/23 11/05/23 10/08/23 09/11/23 19/03/24 14/05/24 - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 - - - - - - -
Net Cash position 1 120 100 137 77.6 - 20.5 59.3
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow -76.7 -72 -52.9 - - - -
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex 1.25 0.4 - - - - -
Capex / Sales 56.25% 72.48% - - - - -
Announcement Date 12/03/20 25/03/21 17/03/22 29/03/23 19/03/24 - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
1.55 USD
Average target price
1 USD
Spread / Average Target
-35.48%
Consensus
  1. Stock Market
  2. Equities
  3. SYBX Stock
  4. Financials Synlogic, Inc.